Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Acta Oncologica (Stockholm, Sweden)|December 25, 2014
Five-year follow-up using a prostate stent as fiducial in image-guided radiotherapy of prostate cancerJesper Carl, Lotte SanderMedical Physics|March 3, 2012
EXACTRAC x-ray and beam isocenters-what's the difference?Dennis Tideman Arp, Jesper CarlRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 20, 2008
A phantom study of dose compensation behind hip prosthesis using portal dosimetry and dynamic MLCMartin Skovmos Nielsen, Jesper Carl, Jane NielsenJournal of Applied Clinical Medical Physics|May 12, 2016
Comparison of manual and automatic MR-CT registration for radiotherapy of prostate cancerAnne Sofie Korsager, Jesper Carl, Lasse Riis ØstergaardActa Oncologica (Stockholm, Sweden)|July 4, 2015
A new method to validate thoracic CT-CT deformable image registration using auto-segmented 3D anatomical landmarksMartin S Nielsen, Lasse R Østergaard, Jesper CarlActa Oncologica (Stockholm, Sweden)|August 30, 2013
Potential position errors using fiducial markers for gated image guided radiotherapyMartin S Nielsen, M W Nyström, Jesper CarlMedical Physics|May 31, 2013
MR-CT registration using a Ni-Ti prostate stent in image-guided radiotherapy of prostate cancerAnne Sofie Korsager, Jesper Carl, Lasse Riis ØstergaardRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 27, 2011
Urethra sparing - potential of combined Nickel-Titanium stent and intensity modulated radiation therapy in prostate cancerJakob Borup Thomsen, Dennis Tideman Arp, Jesper CarlRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 18, 2006
Feasibility study using a Ni-Ti stent and electronic portal imaging to localize the prostate during radiotherapyJesper Carl, Bente Lund, Erik Hoejkjaer Larsen, et al.Acta Oncologica (Stockholm, Sweden)|December 24, 2013
MRI target delineation may reduce long-term toxicity after prostate radiotherapyLotte Sander, Niels Christian Langkilde, Mats Holmberg, et al.Pageof 3